TrialCardiovascular diabetology2014

Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.

Yuko Ohno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.